Roche: Most Of Avastin Business In Europe Is Now Gone

Follows Competition From Biosimilar Bevacizumab Since Last Summer

 
• By Dean Rudge
  
Roche_White_Logo
Amgen and Pfizer were the first moves on biosimilar Avastin in the EU • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products